Among the large, international biotechnology companies in the exhibit hall at ASN Kidney Week was at least one startup ...

Imagine a seamlessly orchestrated flow—studies designed smarter, delivered more smoothly, risks reduced and communications ...

Tired of slow, inconsistent image edits with ChatGPT or other AI tools (including Photoshop)? Discover how Flux Kontext ...

Mechanical ventilation highlights the fundamental paradox of critical care: it can be both life-saving and life-threatening.

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the ...

A Penn-led research team has uncovered how hydralazine, one of the oldest blood pressure medications and a standard treatment for preeclampsia, functions at the molecular level.

The Food and Drug Administration (FDA) has granted accelerated approval to Voyxact ® (sibeprenlimab-szsi) to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk for ...

More than 300 people across academia and industry spilled into an auditorium to attend a BoltzGen seminar on Thursday, Oct.

The FDA will now allow biotechs to ask agency staff for “quick clarifications” via email. Elsewhere, Novartis hiked guidance for two top drugs and a startup nearing “unicorn” status secured a ...

Batteries will soon be heralded for brain power, not size, according to experts from North Carolina's FlexGen.

Toolgen Inc. has entered into a strategic cross-license agreement with Geneditbio Ltd. to jointly advance the development of next-generation in vivo genome-editing therapeutics.